Dr. Apter is attending ASCP Annual Meeting

🔷Starting May 29th, GCT President, Dr. Jeffrey Apter is attending ASCP Annual Meeting in Loews Hotel Miami. The event brings together regulatory specialists from FDA, EMA, NIMH, NIDA, NIAAA and industry key opinion leaders to discuss neuropsychiatric drug development.

🔷Dr. Apter has over 35 years of experience in CNS clinical trials as a PI and KOL. Do not loose a chance to link up with him in Miami or schedule a meeting in advance by contacting BD department!

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.